Antithrombosis Trials: Should We Test Therapeutic Heparin Adjusted Based on Activated Partial Thromboplastin Time in Septic Shock?*
Critical Care Medicine - United States
doi 10.1097/ccm.0b013e31819d2bb4
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2009
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)